Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2026

Conditions

Endometrial Cancer Stage IEndometrial Hyperplasia

Interventions

DRUG

Megestrol Acetate 40 MG

160mg/one time/day

Trial Locations (1)

RECRUITING

Women's Hospital School of Medicine Zhejiang University, Hangzhou

All Listed Sponsors

lead

Women's Hospital School Of Medicine Zhejiang University

OTHER